
Transforming therapy for Acral and Mucosal Melanom...
Mona Foth‘s Abstract Acral and mucosal melanomas(A&MM) are rare but aggressive types of melanoma, making up less than 5% of all cases. Unlike the more common typ...
Learn more about our upcoming Galas and Signature Events Learn More
Superyacht Captain, TV Personality, Melanoma Patient and Advocate Poised to Emcee Event Honoring the Melanoma Community New York City, NY (September 11, 2025) – The...
Mona Foth‘s Abstract Acral and mucosal melanomas(A&MM) are rare but aggressive types of melanoma, making up less than 5% of all cases. Unlike the more common typ...
Emma Clark’s Abstract Melanoma is a disease that places an incredible physical, financial, and emotional burden upon our society. Treatment options for melanoma have ...
Chenxu Shi’s Abstract Melanoma is a deadly form of skin cancer, and while new immunotherapy treatments have significantly improved survival, not all patients respond ...
Dong Ren’s Abstract Sinonasal mucosal melanoma (SNMM) is a rare high-grade malignancy involving the sinonasal tract, primarily including the nasal cavity, turbinates,...
Devarati Mitra’s Abstract Patients with mucosal melanoma are likely to have poor outcomes with current standard-of-care treatment options. The reasons are multifactor...
Medical Student Award – Pritika Parmar
Description: Mucosal melanoma (MM) is a rare form of melanoma with poor survival outcomes. Data on treatment for MM is limited to results from studies on cutaneous melanoma...
Medical Student Awards – Michael Chang
Immunotherapy has fundamentally changed the way we treat melanoma patients. Checkpoint blockade specifically, which unleashes T cell killing of cancer cells, has extended p...
Team Awards – Melanoma Research Program at Georgetown University
Mucosal melanoma presents a significant challenge for oncologists. Compared to cutaneous melanoma, mucosal melanoma has a far lower survival rate and is more difficult to t...
The Susan Fazio Melanoma Research Foundation Award Career Development Award – Iwei Yeh
Oct 16, 2025 ET
Oct 30, 2025 ET